Prosoma’s Living Well app is a clinically validated program, designed explicitly for cancer patients, reduces symptoms of stress, anxiety, and depression related to the diagnosis and treatment of cancer which improves patients’ emotional functioning, quality of life, and overall outcomes.
Year of investment: 2025
Where the company is active: Europe (DACH, PL), USA
What social problem are they responding to: Improve the mental health and treatment outcome of cancer patients.
Main objectives: Redefining mental health care in oncology through digital innovation
Which fund we invested in the company: Impact Venture III.
Reason of investment: Prosoma provides the only self-care solution delivering psychological and behavioral support to cancer patients instantly, cost-effectively, and reliably.
UN sustainability goals:
